Background: Chronic adrenergic stimulation leads to cardiac hypertrophy and heart failure in experimental models and contributes to the progression of heart failure in humans. The pathways mediating the detrimental effects of chronic beta-adrenergic stimulation are only partly understood. We investigated whether genetic modification of calcium handling through deletion of phospholamban in mice would affect the development of heart failure in mice with transgenic overexpression of the beta1-adrenergic receptor.
Methods And Results: We crossed beta1-adrenergic receptor transgenic (beta1TG) mice with mice homozygous for a targeted deletion of the phospholamban gene (PLB-/-). Phospholamban ablation dramatically enhanced survival of beta1TG mice. The decrease of left ventricular contractility typically observed in beta1TG mice was reverted back to normal by phospholamban ablation. Cardiac hypertrophy and fibrosis were significantly inhibited in beta1TG/PLB-/- mice compared with beta1TG mice, and the heart failure-specific gene expression pattern was normalized. Analysis of intracellular calcium transients revealed increased diastolic calcium levels and decreased rate constants of diastolic calcium decline in beta1TG mice. In beta1TG/PLB-/- mice, diastolic calcium concentration was normal and rate constants of diastolic calcium decline were greater than in wild-type mice.
Conclusions: We conclude that modification of abnormal calcium handling in beta1TG mice through ablation of phospholamban resulted in a rescue of functional, morphological, and molecular characteristics of heart failure in beta1-adrenergic receptor-transgenic mice. These results imply altered calcium handling as critical for the detrimental effects of beta1-adrenergic signaling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/01.CIR.0000117254.68497.39 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Protective effects of Gα deficiency in a murine heart-failure model of β-adrenoceptor overexpression.
Naunyn Schmiedebergs Arch Pharmacol
April 2024
Center of Pharmacology, Department II, University of Cologne and University Hospital Cologne, Cologne, Germany.
We have shown that in murine cardiomyopathy caused by overexpression of the β-adrenoceptor, Gα-deficiency is detrimental. Given the growing evidence for isoform-specific Gα-functions, we now examined the consequences of Gα deficiency in the same heart-failure model. Mice overexpressing cardiac β-adrenoceptors with (β-tg) or without Gα-expression (β-tg/Gα) were compared to C57BL/6 wildtypes and global Gα-knockouts (Gα).
View Article and Find Full Text PDFLack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.
Cardiovasc Res
December 2015
Department of Pharmacology, University of Cologne, Gleueler Strasse 24, 50931 Cologne, Germany
Aims: Inhibitory G (Gi) proteins have been proposed to be cardioprotective. We investigated effects of Gαi2 knockout on cardiac function and survival in a murine heart failure model of cardiac β1-adrenoceptor overexpression.
Methods And Results: β1-transgenic mice lacking Gαi2 (β1-tg/Gαi2 (-/-)) were compared with wild-type mice and littermates either overexpressing cardiac β1-adrenoceptors (β1-tg) or lacking Gαi2 (Gαi2 (-/-)).
Interstitial remodeling in beta1-adrenergic receptor transgenic mice.
Basic Res Cardiol
March 2007
Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes Klinik für Innere Medizin III, 66421, Homburg/Saar, Germany.
Background: Inhibition of proteolytic MMP activity could be a therapeutic approach to prevent ventricular dilatation by diminishing collagen matrix turnover and interstitial fibrosis. We investigated the time-course of MMP/TIMP activity during transition from hypertrophy to ventricular dilatation in transgenic mice with myocyte overexpression of the human beta1-adrenergic receptor (beta1TG). These beta1TG mice were studied at 3 (normal function), 5 (hypertrophy) and 12 (ventricular dilatation) months of age compared to age-matched controls (WT).
View Article and Find Full Text PDFBackground: Chronic adrenergic stimulation leads to cardiac hypertrophy and heart failure in experimental models and contributes to the progression of heart failure in humans. The pathways mediating the detrimental effects of chronic beta-adrenergic stimulation are only partly understood. We investigated whether genetic modification of calcium handling through deletion of phospholamban in mice would affect the development of heart failure in mice with transgenic overexpression of the beta1-adrenergic receptor.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!